tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Potential of Annovis Bio’s Buntanetap in Alzheimer’s Treatment Justifies Buy Rating
PremiumRatingsPromising Potential of Annovis Bio’s Buntanetap in Alzheimer’s Treatment Justifies Buy Rating
1M ago
Annovis Bio prices 4M shares at $1.50 in registered direct offering
Premium
The Fly
Annovis Bio prices 4M shares at $1.50 in registered direct offering
1M ago
Annovis Bio announces new results from Phase 2/3 AD study of buntanetap
Premium
The Fly
Annovis Bio announces new results from Phase 2/3 AD study of buntanetap
1M ago
Annovis Bio Reports Q2 2025 Progress and Financials
PremiumCompany AnnouncementsAnnovis Bio Reports Q2 2025 Progress and Financials
3M ago
Annovis Bio’s Promising Alzheimer’s Drug Trial: What Investors Need to Know
Premium
Company Announcements
Annovis Bio’s Promising Alzheimer’s Drug Trial: What Investors Need to Know
3M ago
Annovis Bio’s Strategic Advancements and Phase 3 Study Progress Support Buy Rating
Premium
Ratings
Annovis Bio’s Strategic Advancements and Phase 3 Study Progress Support Buy Rating
3M ago
Annovis Bio’s Promising Alzheimer’s Study: A Potential Game Changer?
PremiumCompany AnnouncementsAnnovis Bio’s Promising Alzheimer’s Study: A Potential Game Changer?
5M ago
Annovis Bio rises 16.3%
Premium
The Fly
Annovis Bio rises 16.3%
5M ago
Annovis Bio Approves Board Elections and Auditor Appointment
Premium
Company Announcements
Annovis Bio Approves Board Elections and Auditor Appointment
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100